Immatics
IMTX
#5829
Rank
โ‚น119.82 B
Marketcap
โ‚น876.69
Share price
-2.26%
Change (1 day)
57.21%
Change (1 year)

Revenue for Immatics (IMTX)

Revenue in 2026 (TTM): โ‚น3.92 Billion

According to Immatics's latest financial reports the company's current revenue (TTM ) is โ‚น4.21 Billion. In 2025 the company made a revenue of โ‚น4.93 Billion a decrease over the revenue in the year 2024 that were of โ‚น14.38 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Immatics from 2020 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น3.92 B-20.45%
2025 โ‚น4.93 B-65.68%
2024 โ‚น14.38 B193.23%
2023 โ‚น4.90 B-68.32%
2022 โ‚น15.48 B418.68%
2021 โ‚น2.98 B12.26%
2020 โ‚น2.65 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas
NRC Health
NRC
โ‚น13.38 B 217.30%๐Ÿ‡บ๐Ÿ‡ธ USA